Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outcomes By Cardiac Stage in Newly Diagnosed AL Amyloidosis: Results from Andromeda

Monique C. Minnema, Angela Dispenzieri, MD, Giampaolo Merlini, MD, Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM, Martha Grogan, MD, Ronald Witteles, MD, Frederick L. Ruberg, MD, Mathew S. Maurer, MD, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Arnaud Jaccard, MD PhD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-139754

Published: 2020

Journal Articles

Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses

Alfred Chung, MD, Gregory P. Kaufman, MD, Surbhi Sidana, MD, David Iberri, MD, Erik Eckhert, MD MS, Stanley Schrier, MD, Richard Lafayette, MD, Sally Arai, MD, Ronald Witteles, MD, Michaela Liedtke, MD

Blood (2019) 134 (Supplement_1): 1884.

https://doi.org/10.1182/blood-2019-124981

Published: 2019

Journal Articles

Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis

Alfred Chung, MD, Gregory P. Kaufman, MD, Surbhi Sidana, MD, Erik Eckhert, MD MS, Stanley Schrier, MD, Sally Arai, MD, Richard Lafayette, MD, Ronald Witteles, MD, Michaela Liedtke, MD

Blood (2019) 134 (Supplement_1): 1828.

https://doi.org/10.1182/blood-2019-122152

Published: 2019

Journal Articles

Graded Cardiac Response Correlates with Relapse and Survival in AL Amyloidosis

Erik Keith Eckhert, MD MS, Ronald Witteles, MD, Gregory Kaufman, MD, Richard Lafayette, MD, Sally Arai, MD, Stanley Schrier, MD, Michelle O'Shaughnessy, MB BCh MS, Michaela Liedtke, MD

Blood (2018) 132 (Supplement 1): 4486.

https://doi.org/10.1182/blood-2018-99-113577

Published: 2018

Journal Articles

Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis

Eric Mou, MD, Henry Kwang, MD, Jason Hom, MD, Lisa Shieh, MD, Neera Ahuja, MD, Stephanie Harman, MD, Tyler Johnson, MD, Andre Kumar, MD, Neil Shah, MD, Ronald Witteles, MD, Caroline Berube, MD FRCP(C)

Blood (2016) 128 (22): 2330.

https://doi.org/10.1182/blood.V128.22.2330.2330

Published: 2016

Journal Articles

Hematologic Responses and Cardiac Organ Improvement in Patients with Heavily Pretreated Cardiac Immunoglobulin Light Chain (AL) Amyloidosis Receiving Daratumumab

Gregory Kaufman, MD, Ronald Witteles, MD, Matthew Wheeler, MD, Patricia Ulloa, RN, Marie Lugtu, RN, Sally Arai, MD, Stanley Schrier, MD, Richard Lafayette, MD, Michaela Liedtke, MD

Blood (2016) 128 (22): 4525.

https://doi.org/10.1182/blood.V128.22.4525.4525

Published: 2016

Journal Articles

A Pilot Study of Melphalan, Lenalidomide and Dexamethasone In AL Amyloidosis: Interim Results

Anosheh Afghahi, MD, Wesley Witteles, MD, Ronald Witteles, MD, Michaela Liedtke, MD, Richard Lafayette, MD, Sally Arai, MD, Stanley L. Schrier, MD

Blood (2010) 116 (21): 1946.

https://doi.org/10.1182/blood.V116.21.1946.1946

Published: 2010

Journal Articles

AL Amyloidosis and Concomitant Myeloma: Time to Reconsider Assumptions

Wesley Witteles, MD, Ronald Witteles, MD, Michaela Liedtke, MD, Sally Arai, MD, Richard Lafayette, MD, Tracy I. George, MD, Stanley L. Schrier, MD

Blood (2010) 116 (21): 4044.

https://doi.org/10.1182/blood.V116.21.4044.4044

Published: 2010

Journal Articles

AL Amyloidosis: Prognosis of Cardiac Involvement Reconsidered.

Wesley Witteles, MD, Ronald Witteles, MD, Sally Arai, MD, Richard Lafayette, MD, Stanley Schrier, MD

Blood (2009) 114 (22): 4872.

https://doi.org/10.1182/blood.V114.22.4872.4872

Published: 2009

NARROW

Outcomes By Cardiac Stage in Newly Diagnosed AL Amyloidosis: Results from Andromeda

Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses

Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis

Graded Cardiac Response Correlates with Relapse and Survival in AL Amyloidosis

Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis

Hematologic Responses and Cardiac Organ Improvement in Patients with Heavily Pretreated Cardiac Immunoglobulin Light Chain (AL) Amyloidosis Receiving Daratumumab

A Pilot Study of Melphalan, Lenalidomide and Dexamethasone In AL Amyloidosis: Interim Results

AL Amyloidosis and Concomitant Myeloma: Time to Reconsider Assumptions

AL Amyloidosis: Prognosis of Cardiac Involvement Reconsidered.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only